πŸ‡ΊπŸ‡Έ FDA
Patent

US 6211336

Ataxia-telangiectasia gene

expired A61KA61K38/00

Quick answer

US patent 6211336 (Ataxia-telangiectasia gene) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00